Who
Paul Gisbert Auwaerter
Director
Company insider
Files Form 4 as: Director, Capricor Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 0
- Bought
- $14K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 11 Jul 2023
- Last trade
- 5 Jan 2026
- Last filed
- 7 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,420 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,420 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,940 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,440 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,250 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —890 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,760 at $0.00 | filing |
| 6 Oct 2023filed 10 Oct 2023 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | $14K5,000 at $2.84 | filing |
| 11 Jul 2023filed 13 Jul 2023 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.